IL6 and eosinophilia-myalgia syndrome: In conclusion, employing a 2-sample MR approach, our evidence suggests that genetically predicted elevated levels of IL-6 are associated with an increased risk of EMs, while elevated levels of platelet-derived growth factor are linked to a reduced incidence of EMs.